Charles Schwab
NUTX

Charles Schwab’s Nutex Health NUTX Stock Holding History

Charles Schwab’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.74M Buy
16,028
+965
+6% +$122K ﹤0.01% 2679
2026
Q1 		$1.43M Buy
15,063
+4,849
+47% +$595K ﹤0.01% 2800
2025
Q4 		$1.68M Sell
10,214
-26
-0.3% -$3.45K ﹤0.01% 2788
2025
Q3 		$1.06M Hold
10,240
– – ﹤0.01% 2932
2025
Q2 		$1.27M Buy
+10,240
New +$1.32M ﹤0.01% 2824
2023
Q2 		– Sell
-3,796
Closed -$575K – 3659
2023
Q1 		$575K Buy
3,796
+55
+1% +$11.1K ﹤0.01% 2906
2022
Q4 		$1.07M Buy
3,741
+3,173
+559% +$609K ﹤0.01% 2755
2022
Q3 		$128K Hold
568
– – ﹤0.01% 3202
2022
Q2 		$275K Buy
+568
New +$670K ﹤0.01% 3197

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Charles Schwab's NUTX Position: Q2 2026 in Review

Charles Schwab increased its Nutex Health (NUTX) stake by 6.4% in Q2 2026, buying an estimated $122K and bringing the position to 16,028 shares worth $2.74M. The position accounts for ﹤0.01% of the portfolio, ranked #2679.

Charles Schwab first reported a position in NUTX in Q2 2022 and has held it in 9 quarters since. 153 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Charles Schwab held 16,028 shares of Nutex Health worth $2.74M as of Q2 2026.
  • Charles Schwab bought 965 Nutex Health shares in Q2 2026, an estimated $122K.
  • Nutex Health made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2679 holding.
  • Charles Schwab first reported a position in Nutex Health in Q2 2022 and has held it in 9 quarters since.
  • 153 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.